FOXP3 and type 1 diabetes mellitus: Given their nonredundant function in maintaining immune homeostasis, it is not surprising that Foxp3+ Treg cells have attracted considerable attention as particularly promising gain-of-function targets in clinical settings of unwanted immune responses, such as T1D.